Clinic
Childrens Hospital of Philadelphia
Childrens Hospital of Philadelphia was paid $286.88M by Medicaid between Jan 2018 and Dec 2024, across 540 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoCHILDRENS HOSPITAL OF PHILADELPHIA
PHILADELPHIA, PA 19104
PHILADELPHIA, PA 19104
33aNPI1215921457assigned 09/02/2005
33bProvider typeClinic/Center
28Total paid$286.88M
24GClaims1,676,908
24DCodes billed540
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#1 of 176
Median peer was paid$441K
This provider vs. median651×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 113,541 | $13.51M | |
| 2019 | 142,539 | $13.28M | |
| 2020 | 192,765 | $24.37M | |
| 2021 | 488,905 | $83.26M | |
| 2022 | 208,973 | $49.43M | |
| 2023 | 272,303 | $54.25M | |
| 2024incomplete | 257,882 | $48.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 91,802 | 89,981 | $54.84M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 65,227 | 63,963 | $38.37M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 59,805 | 58,424 | $35.56M |
| G0378 | Hospital observation service, per hour | 7.3% | 24,078 | 12,250 | $20.99M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5.6% | 6,192 | 5,670 | $16.02M |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3.6% | 3,279 | 2,815 | $10.23M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 2.8% | 34,156 | 1,852 | $7.94M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 4,806 | 4,561 | $3.77M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.3% | 2,560 | 2,254 | $3.63M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.2% | 5,795 | 5,488 | $3.58M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.2% | 3,540 | 3,000 | $3.54M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.2% | 2,043 | 1,630 | $3.51M |
528 more codes
| J3490 | Unclassified drugs | 1.1% | 48,848 | $3.21M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 3,558 | $2.46M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 35,666 | $2.35M |
| 93325 | <1% | 17,366 | $2.34M | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 9,202 | $2.28M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 989 | $2.15M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 6,698 | $2.09M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 66,712 | $2.06M |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 704 | $2.00M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 60,671 | $1.58M |
| 36430 | <1% | 2,639 | $1.48M | |
| 76770 | <1% | 6,128 | $1.41M | |
| 80053 | Comprehensive metabolic panel | <1% | 46,273 | $1.40M |
| 93304 | <1% | 4,262 | $1.20M | |
| 95782 | <1% | 761 | $1.17M | |
| 36512 | <1% | 389 | $1.17M | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 1,655 | $1.04M |
| 94010 | <1% | 6,394 | $1.02M | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,546 | $1.00M |
| 93308 | <1% | 2,840 | $1000K | |
| OP370 | <1% | 8,546 | $978K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 10,922 | $924K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,038 | $921K |
| 54161 | <1% | 268 | $881K | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 19,352 | $787K |
| OP710 | <1% | 8,563 | $734K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 25,807 | $728K |
| 93320 | <1% | 5,546 | $726K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 10,296 | $720K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,587 | $711K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 3,067 | $702K |
| A4649 | Surgical supply; miscellaneous | <1% | 4,540 | $697K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15,018 | $688K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12,727 | $686K |
| 86850 | <1% | 7,294 | $629K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 5,573 | $603K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 89,077 | $595K |
| 93225 | <1% | 2,335 | $572K | |
| 93321 | <1% | 6,961 | $568K | |
| 64642 | <1% | 203 | $555K | |
| 85027 | <1% | 17,243 | $543K | |
| 92523 | <1% | 3,091 | $540K | |
| 92567 | <1% | 15,538 | $520K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 4,824 | $514K |
| 92587 | <1% | 9,809 | $511K | |
| 70543 | <1% | 503 | $489K | |
| 83655 | <1% | 10,196 | $488K | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 12,135 | $481K |
| 76825 | <1% | 1,252 | $466K | |
| 86356 | <1% | 1,602 | $455K | |
| 97162 | <1% | 5,463 | $453K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13,953 | $450K |
| 95816 | <1% | 3,281 | $446K | |
| 86900 | <1% | 7,269 | $445K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,290 | $444K |
| 67311 | <1% | 156 | $432K | |
| 82728 | <1% | 9,737 | $417K | |
| 92552 | <1% | 9,254 | $406K | |
| 49452 | <1% | 129 | $380K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,333 | $368K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 539 | $365K |
| 84100 | <1% | 21,903 | $361K | |
| 85045 | <1% | 12,608 | $357K | |
| 74183 | <1% | 315 | $353K | |
| 82784 | <1% | 7,335 | $351K | |
| 80061 | Lipid panel | <1% | 10,944 | $344K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,542 | $343K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,540 | $343K |
| 81229 | <1% | 657 | $337K | |
| 83020 | <1% | 4,378 | $328K | |
| 72082 | <1% | 2,549 | $325K | |
| 83735 | <1% | 18,926 | $320K | |
| 97166 | <1% | 3,165 | $319K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,583 | $316K |
| 86902 | <1% | 1,241 | $315K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,382 | $309K |
| 92610 | <1% | 3,856 | $300K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13,116 | $291K |
| 86832 | <1% | 1,649 | $288K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,024 | $285K |
| 86833 | <1% | 1,642 | $282K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 294 | $279K |
| 76820 | <1% | 3,616 | $276K | |
| 72197 | <1% | 276 | $273K | |
| 75561 | <1% | 273 | $271K | |
| 86140 | <1% | 10,943 | $270K | |
| 84466 | <1% | 7,106 | $266K | |
| 95700 | <1% | 739 | $262K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,141 | $260K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 36,109 | $258K |
| 93886 | <1% | 297 | $252K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,376 | $251K |
| 76827 | <1% | 1,248 | $240K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,761 | $238K |
| 80197 | <1% | 5,351 | $232K | |
| 86901 | <1% | 7,280 | $228K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 854 | $216K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 4,704 | $204K |
| 72141 | <1% | 317 | $203K | |
| 96409 | <1% | 1,275 | $202K | |
| 81415 | <1% | 116 | $195K | |
| 87799 | <1% | 2,903 | $194K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,724 | $190K |
| J2704 | Injection, propofol, 10 mg | <1% | 26,026 | $180K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 977 | $178K |
| 86923 | <1% | 4,046 | $177K | |
| 97163 | <1% | 1,147 | $170K | |
| 97164 | <1% | 2,062 | $169K | |
| 85652 | <1% | 8,411 | $168K | |
| 92555 | <1% | 10,164 | $164K | |
| 83970 | <1% | 3,578 | $161K | |
| 86360 | <1% | 1,393 | $160K | |
| 86255 | <1% | 2,954 | $160K | |
| 83880 | <1% | 3,077 | $159K | |
| 82977 | <1% | 7,889 | $158K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,463 | $156K |
| 83540 | <1% | 7,140 | $156K | |
| 72146 | <1% | 227 | $154K | |
| 97803 | <1% | 1,751 | $151K | |
| 77072 | <1% | 2,308 | $150K | |
| 93975 | <1% | 309 | $149K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,534 | $148K |
| 84439 | <1% | 4,427 | $148K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 537 | $148K |
| 83516 | <1% | 3,047 | $139K | |
| 87497 | <1% | 2,195 | $138K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 612 | $136K |
| 69210 | <1% | 67 | $135K | |
| 73610 | <1% | 1,450 | $133K | |
| 74018 | <1% | 2,716 | $128K | |
| 70544 | <1% | 162 | $126K | |
| 42830 | <1% | 55 | $123K | |
| 72081 | <1% | 1,391 | $119K | |
| 97168 | <1% | 1,772 | $118K | |
| 81003 | <1% | 14,434 | $117K | |
| 73630 | <1% | 1,439 | $116K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,372 | $114K |
| 85610 | <1% | 5,697 | $108K | |
| 29075 | <1% | 686 | $105K | |
| 84703 | <1% | 6,498 | $105K | |
| 82610 | <1% | 3,370 | $104K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 93 | $103K |
| 86355 | <1% | 1,507 | $101K | |
| 76821 | <1% | 548 | $101K | |
| 83615 | <1% | 2,713 | $100K | |
| P9011 | Blood, split unit | <1% | 283 | $100K |
| 90686 | <1% | 1,563 | $99K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,712 | $99K |
| A4550 | Surgical trays | <1% | 8,409 | $98K |
| 76886 | <1% | 382 | $97K | |
| 96415 | <1% | 654 | $94K | |
| 86359 | <1% | 1,430 | $94K | |
| 72170 | <1% | 1,304 | $94K | |
| 73590 | <1% | 1,224 | $94K | |
| 73090 | <1% | 1,276 | $94K | |
| 92553 | <1% | 2,307 | $92K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,956 | $91K |
| 86317 | <1% | 674 | $87K | |
| 73521 | <1% | 1,146 | $86K | |
| 74240 | <1% | 416 | $86K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 7,103 | $85K |
| 85730 | <1% | 3,526 | $85K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,986 | $85K |
| 73100 | <1% | 801 | $83K | |
| 82248 | <1% | 3,838 | $82K | |
| 80076 | <1% | 3,316 | $82K | |
| 86592 | <1% | 1,932 | $82K | |
| 95708 | <1% | 310 | $80K | |
| 94621 | <1% | 207 | $79K | |
| 94060 | <1% | 472 | $79K | |
| 73070 | <1% | 1,109 | $78K | |
| 83520 | <1% | 1,533 | $78K | |
| 84305 | <1% | 1,743 | $76K | |
| 97165 | <1% | 1,149 | $75K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 6,081 | $74K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 290 | $74K |
| 20680 | <1% | 28 | $73K | |
| 70360 | <1% | 933 | $71K | |
| 29065 | <1% | 338 | $69K | |
| 84460 | <1% | 1,648 | $68K | |
| 76000 | <1% | 1,037 | $67K | |
| 78264 | <1% | 164 | $66K | |
| 72156 | <1% | 72 | $65K | |
| 82947 | <1% | 4,983 | $65K | |
| 51701 | <1% | 384 | $64K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 11,358 | $64K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 355 | $63K |
| 86357 | <1% | 845 | $62K | |
| 84450 | <1% | 1,518 | $61K | |
| 96450 | <1% | 101 | $61K | |
| 97161 | <1% | 1,095 | $60K | |
| 73110 | <1% | 532 | $60K | |
| 73140 | <1% | 671 | $59K | |
| L4386 | Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 1,219 | $59K |
| 76536 | <1% | 302 | $59K | |
| 97802 | <1% | 523 | $59K | |
| 73560 | <1% | 816 | $58K | |
| 84436 | <1% | 3,002 | $57K | |
| 31622 | <1% | 30 | $56K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 541 | $55K |
| 92652 | <1% | 208 | $54K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 106 | $54K |
| 84403 | <1% | 825 | $54K | |
| 87081 | <1% | 4,528 | $54K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 5,539 | $53K |
| 82139 | <1% | 1,251 | $51K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 286 | $51K |
| 83498 | <1% | 333 | $51K | |
| 81001 | <1% | 3,675 | $51K | |
| 87186 | <1% | 2,275 | $50K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,971 | $50K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12,845 | $49K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,482 | $48K |
| 93976 | <1% | 219 | $48K | |
| 82570 | <1% | 2,701 | $48K | |
| 97167 | <1% | 435 | $47K | |
| 92557 | <1% | 808 | $46K | |
| 77073 | <1% | 445 | $46K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 1,477 | $44K |
| 82010 | <1% | 2,834 | $44K | |
| 87340 | <1% | 641 | $44K | |
| 73130 | <1% | 616 | $43K | |
| 97116 | <1% | 1,158 | $43K | |
| 76870 | <1% | 255 | $43K | |
| 80050 | General health panel | <1% | 195 | $42K |
| 87070 | <1% | 2,864 | $42K | |
| 81243 | <1% | 347 | $42K | |
| 73564 | <1% | 299 | $42K | |
| 87536 | <1% | 479 | $41K | |
| 86803 | <1% | 748 | $41K | |
| 83002 | <1% | 995 | $41K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 341 | $40K |
| 83001 | <1% | 900 | $39K | |
| 81416 | <1% | 38 | $39K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 753 | $38K |
| 74230 | <1% | 318 | $37K | |
| OP272 | <1% | 4,271 | $37K | |
| 86480 | <1% | 753 | $36K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 290 | $36K |
| 82550 | <1% | 2,227 | $36K | |
| 82785 | <1% | 765 | $34K | |
| 69610 | <1% | 22 | $34K | |
| 51600 | <1% | 14 | $34K | |
| 96367 | <1% | 376 | $34K | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 2,672 | $34K |
| 82670 | <1% | 485 | $33K | |
| 83690 | <1% | 2,271 | $33K | |
| A9150 | Non-prescription drugs | <1% | 4,091 | $32K |
| 92604 | <1% | 315 | $32K | |
| 92524 | <1% | 502 | $32K | |
| 75565 | <1% | 229 | $32K | |
| 99157 | <1% | 116 | $32K | |
| 85018 | <1% | 1,834 | $31K | |
| 84630 | <1% | 1,043 | $31K | |
| 85246 | <1% | 388 | $31K | |
| 82542 | <1% | 543 | $31K | |
| 76800 | <1% | 123 | $31K | |
| 72157 | <1% | 37 | $31K | |
| 84146 | <1% | 542 | $30K | |
| 87077 | <1% | 3,402 | $30K | |
| 87040 | <1% | 1,455 | $30K | |
| 92556 | <1% | 1,064 | $30K | |
| 80230 | <1% | 333 | $30K | |
| 64644 | <1% | 15 | $29K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,836 | $29K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,231 | $29K |
| 86706 | <1% | 522 | $28K | |
| 92593 | <1% | 964 | $28K | |
| 83921 | <1% | 519 | $28K | |
| 92602 | <1% | 281 | $28K | |
| 82607 | <1% | 950 | $28K | |
| 36591 | <1% | 952 | $28K | |
| 80195 | <1% | 851 | $27K | |
| 81268 | <1% | 51 | $27K | |
| 74019 | <1% | 840 | $27K | |
| 82330 | <1% | 1,278 | $27K | |
| 96411 | <1% | 315 | $26K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,601 | $26K |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 6,714 | $25K |
| OP270 | <1% | 1,917 | $25K | |
| J2515 | Injection, pentobarbital sodium, per 50 mg | <1% | 1,000 | $25K |
| 85240 | <1% | 391 | $25K | |
| 82803 | <1% | 1,350 | $24K | |
| 83525 | <1% | 397 | $24K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 102 | $24K |
| 71250 | <1% | 77 | $24K | |
| 54640 | <1% | 12 | $24K | |
| 86361 | <1% | 238 | $23K | |
| 86003 | <1% | 549 | $23K | |
| 85245 | <1% | 369 | $23K | |
| 94799 | <1% | 422 | $22K | |
| 94729 | <1% | 182 | $22K | |
| 82379 | <1% | 319 | $21K | |
| 82948 | <1% | 3,964 | $21K | |
| 72158 | <1% | 28 | $21K | |
| 84479 | <1% | 1,640 | $21K | |
| 29425 | <1% | 291 | $21K | |
| 87631 | <1% | 119 | $21K | |
| A4651 | Calibrated microcapillary tube, each | <1% | 2,498 | $21K |
| 76377 | <1% | 191 | $20K | |
| 74181 | <1% | 41 | $20K | |
| 86704 | <1% | 359 | $20K | |
| 84446 | <1% | 457 | $19K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 2,346 | $19K |
| 0002A | <1% | 1,246 | $19K | |
| 88313 | <1% | 436 | $19K | |
| 92651 | <1% | 92 | $18K | |
| 82017 | <1% | 269 | $18K | |
| 84295 | <1% | 1,206 | $18K | |
| 89051 | <1% | 720 | $17K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 188 | $17K |
| 87205 | <1% | 1,616 | $17K | |
| 87102 | <1% | 1,002 | $16K | |
| 82105 | <1% | 284 | $16K | |
| 82150 | <1% | 876 | $16K | |
| 82627 | <1% | 324 | $16K | |
| 86160 | <1% | 174 | $16K | |
| 86774 | <1% | 348 | $16K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 10,943 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 403 | $16K |
| 64643 | <1% | 12 | $16K | |
| 72100 | <1% | 135 | $16K | |
| 73000 | <1% | 174 | $15K | |
| 86665 | <1% | 190 | $15K | |
| 71045 | Radiologic examination, chest; single view | <1% | 689 | $15K |
| 83993 | <1% | 209 | $15K | |
| C1769 | Guide wire | <1% | 752 | $15K |
| 86945 | <1% | 289 | $15K | |
| 84134 | <1% | 726 | $15K | |
| 92591 | <1% | 203 | $15K | |
| 82157 | <1% | 228 | $14K | |
| 84132 | <1% | 1,148 | $14K | |
| 82043 | <1% | 303 | $14K | |
| 73552 | <1% | 343 | $14K | |
| 86038 | <1% | 327 | $14K | |
| 73080 | <1% | 114 | $14K | |
| 86364 | <1% | 403 | $13K | |
| 93226 | <1% | 96 | $13K | |
| 83519 | <1% | 377 | $13K | |
| 0001A | <1% | 1,306 | $13K | |
| 72040 | <1% | 146 | $13K | |
| 83605 | <1% | 409 | $13K | |
| 84550 | <1% | 836 | $12K | |
| 86231 | <1% | 382 | $12K | |
| 92585 | <1% | 68 | $11K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 2,815 | $11K |
| 84156 | <1% | 920 | $11K | |
| 84402 | <1% | 100 | $11K | |
| 82533 | <1% | 338 | $11K | |
| 86235 | <1% | 57 | $10K | |
| 93296 | <1% | 39 | $10K | |
| 12001 | <1% | 31 | $10K | |
| 84590 | <1% | 360 | $10K | |
| 85384 | <1% | 180 | $10K | |
| 80069 | <1% | 41 | $10K | |
| 86922 | <1% | 187 | $10K | |
| 86225 | <1% | 167 | $10K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 124 | $10K |
| 86376 | <1% | 390 | $9K | |
| 99155 | <1% | 100 | $9K | |
| 88342 | <1% | 166 | $9K | |
| 77080 | <1% | 153 | $9K | |
| 87430 | <1% | 1,436 | $9K | |
| 92607 | <1% | 96 | $8K | |
| 87634 | <1% | 111 | $8K | |
| 73060 | <1% | 120 | $8K | |
| 95079 | <1% | 33 | $8K | |
| 86708 | <1% | 153 | $8K | |
| 81267 | <1% | 46 | $8K | |
| 84480 | <1% | 193 | $8K | |
| 84210 | <1% | 142 | $8K | |
| 73030 | <1% | 85 | $7K | |
| 88304 | <1% | 134 | $7K | |
| 86664 | <1% | 189 | $7K | |
| 86663 | <1% | 189 | $7K | |
| 86787 | <1% | 166 | $7K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 552 | $7K |
| 87529 | <1% | 124 | $7K | |
| 86618 | <1% | 75 | $7K | |
| 85379 | <1% | 130 | $7K | |
| 76506 | <1% | 29 | $6K | |
| 95076 | <1% | 52 | $6K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 43 | $6K |
| 89230 | <1% | 78 | $6K | |
| 92592 | <1% | 280 | $6K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,044 | $6K |
| 70486 | <1% | 30 | $6K | |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 855 | $6K |
| 77074 | <1% | 30 | $6K | |
| A6532 | Gradient compression stocking, below knee, 40-50 mmhg, used as a surgical dressing, each | <1% | 238 | $6K |
| 82746 | <1% | 125 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 43 | $6K |
| 74712 | <1% | 13 | $6K | |
| 82140 | <1% | 139 | $5K | |
| 86648 | <1% | 106 | $5K | |
| 86880 | <1% | 75 | $5K | |
| 73620 | <1% | 54 | $4K | |
| 82040 | <1% | 139 | $4K | |
| 87501 | <1% | 58 | $4K | |
| 12011 | <1% | 62 | $4K | |
| 88185 | <1% | 72 | $4K | |
| 82390 | <1% | 170 | $4K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | <1% | 155 | $4K |
| 76882 | <1% | 197 | $4K | |
| 82657 | <1% | 32 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $4K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,994 | $4K |
| 94726 | <1% | 42 | $4K | |
| 82960 | <1% | 168 | $4K | |
| 80164 | <1% | 89 | $4K | |
| 83918 | <1% | 78 | $4K | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 1,382 | $4K |
| 86039 | <1% | 59 | $4K | |
| 84270 | <1% | 117 | $4K | |
| 73562 | <1% | 31 | $4K | |
| 84520 | <1% | 127 | $3K | |
| 87581 | <1% | 241 | $3K | |
| 87147 | <1% | 491 | $3K | |
| 82525 | <1% | 98 | $3K | |
| 74241 | <1% | 39 | $3K | |
| 82985 | <1% | 101 | $3K | |
| 88312 | <1% | 30 | $3K | |
| 82340 | <1% | 150 | $3K | |
| 88307 | <1% | 28 | $3K | |
| 88341 | <1% | 20 | $3K | |
| 88184 | <1% | 89 | $3K | |
| 90656 | <1% | 249 | $3K | |
| 78999 | <1% | 12 | $3K | |
| 85014 | <1% | 206 | $3K | |
| 87177 | <1% | 70 | $3K | |
| 85055 | <1% | 79 | $3K | |
| 85520 | <1% | 48 | $3K | |
| 92586 | <1% | 50 | $3K | |
| 87209 | <1% | 70 | $3K | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 560 | $3K |
| 82810 | <1% | 88 | $2K | |
| A4215 | Needle, sterile, any size, each | <1% | 689 | $2K |
| 86800 | <1% | 207 | $2K | |
| 87107 | <1% | 193 | $2K | |
| 83789 | <1% | 43 | $2K | |
| 84702 | <1% | 58 | $2K | |
| 86644 | <1% | 48 | $2K | |
| 87181 | <1% | 68 | $2K | |
| 82024 | <1% | 206 | $2K | |
| 86682 | <1% | 139 | $2K | |
| 86008 | <1% | 93 | $2K | |
| 88311 | <1% | 31 | $2K | |
| 73660 | <1% | 15 | $2K | |
| 87329 | <1% | 28 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 15 | $2K |
| 87328 | <1% | 28 | $2K | |
| 92608 | <1% | 28 | $2K | |
| 82308 | <1% | 17 | $1K | |
| 82310 | <1% | 53 | $1K | |
| 84478 | <1% | 71 | $1K | |
| 82180 | <1% | 26 | $1K | |
| 87338 | <1% | 39 | $1K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 70 | $1K |
| B4036 | Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | <1% | 237 | $1K |
| 86985 | <1% | 30 | $1K | |
| S0080 | Injection, pentamidine isethionate, 300 mg | <1% | 15 | $1K |
| 84484 | <1% | 47 | $1K | |
| 94770 | <1% | 64 | $1K | |
| J9250 | Methotrexate sodium, 5 mg | <1% | 418 | $1K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $1K |
| 81002 | <1% | 142 | $1K | |
| A4212 | Non-coring needle or stylet with or without catheter | <1% | 86 | $1K |
| 84255 | <1% | 14 | $1K | |
| 86353 | <1% | 14 | $1K | |
| 85347 | <1% | 80 | $1K | |
| 96376 | <1% | 110 | $910.31 | |
| 88108 | <1% | 25 | $678.52 | |
| 82438 | <1% | 24 | $667.98 | |
| 85097 | <1% | 14 | $625.26 | |
| 86256 | <1% | 14 | $595.26 | |
| 94644 | <1% | 237 | $570.48 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 3,203 | $525.02 |
| 82652 | <1% | 25 | $511.89 | |
| 82247 | <1% | 15 | $468.43 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,154 | $440.46 |
| 92590 | <1% | 17 | $436.78 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 1,067 | $432.45 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 315 | $414.85 |
| 82085 | <1% | 13 | $400.67 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 398 | $398.00 |
| A9152 | Single vitamin/mineral/trace element, oral, per dose, not otherwise specified | <1% | 31 | $392.52 |
| C1726 | Catheter, balloon dilatation, non-vascular | <1% | 12 | $301.65 |
| 85013 | <1% | 89 | $288.21 | |
| 82103 | <1% | 26 | $275.58 | |
| 82951 | <1% | 12 | $269.24 | |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | <1% | 13 | $204.80 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 80 | $170.04 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $128.96 |
| S0028 | Injection, famotidine, 20 mg | <1% | 36 | $117.08 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 61 | $99.13 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 216 | $93.61 |
| 86308 | <1% | 40 | $71.11 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 29 | $41.58 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 428 | $24.83 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 769 | $22.38 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 104 | $0.00 |
| J7699 | Noc drugs, inhalation solution administered through dme | 0% | 603 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 69 | $0.00 |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | 0% | 32 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 570 | $0.00 |
| J9260 | Injection, methotrexate sodium, 50 mg | 0% | 93 | $0.00 |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 0% | 115 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 235 | $0.00 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 0% | 118 | $0.00 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 0% | 16 | $0.00 |
| S0077 | Injection, clindamycin phosphate, 300 mg | 0% | 24 | $0.00 |
| J0791 | Injection, crizanlizumab-tmca, 5 mg | 0% | 13 | $0.00 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 0% | 21 | $0.00 |
| 94645 | 0% | 29 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 13 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 34 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 237 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 629 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 41 | $0.00 |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 0% | 41 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 222 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 0% | 14 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 0% | 108 | $0.00 |
| J0586 | Injection, abobotulinumtoxina, 5 units | 0% | 174 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 45 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 32 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 16 | $0.00 |
| J9312 | Injection, rituximab, 10 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, DIERDRA (DIRECTOR)